BlackRock Fund Advisors’s Voyager Therapeutics VYGR Stock Holding History

BlackRock Fund Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.91M	Buy	385,055 +55,394	+17%	+$712K	﹤0.01%	2946
2016 Q3	$3.96M	Buy	329,661 +26,690	+9%	+$361K	﹤0.01%	2956
2016 Q2	$3.33M	Buy	302,971 +156,443	+107%	+$1.91M	﹤0.01%	3034
2016 Q1	$1.28M	Sell	146,528 -7,822	-5%	-$88.7K	﹤0.01%	3163
2015 Q4	$3.38M	Buy	+154,350	New	+$3.56M	﹤0.01%	3012

Other funds holding VYGR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Fund Advisors's VYGR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Voyager Therapeutics (VYGR) stake by 17% in Q4 2016, buying an estimated $712K and bringing the position to 385,055 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

BlackRock Fund Advisors first reported a position in VYGR in Q4 2015 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold VYGR as of Q4 2016.

BlackRock Fund Advisors held 385,055 shares of Voyager Therapeutics worth $4.91M as of Q4 2016.
BlackRock Fund Advisors bought 55,394 Voyager Therapeutics shares in Q4 2016, an estimated $712K.
Voyager Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2946 holding.
BlackRock Fund Advisors first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 5 quarters since.
56 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.